IMCB (Gemabank) is a medical company and market leader among stem cell banks in Russia. It offers services in collection, isolation, cryopreservation and storage of PC ICs. It occupies about 44% of the Russian market at the end of 2018 by the number of samples in storage.
P/E
Net profit
P/B
Book value
P/FCF
FCF
Yield
Growth potential
IMCB news
31.10.2024
Board of Directors of IMCB recommended that dividends be paid for 9 months 2024 in the amount of ₽2.7 per ordinary share. The last day of the purchase of securities to receive dividends is December 16, 2024. Dividend yield may amount to 1.97%.
Source: 
e-disclosure.ru
e-disclosure.ru
29.10.2024
IMCB's RAS net profit for 9 months of 2024 amounted to ₽115.1 million, up 5.7% from ₽108.9 million in the previous year. Revenue increased by 20.2% to ₽256.6 million against ₽213.4 million a year earlier.
Source: e-disclosure.ru
e-disclosure.ru
09.09.2024
Shareholders of IMCB approved dividends for 6 months 2024 in the amount of ₽5 per ordinary share. The last day of purchase of securities to receive dividends is September 13, 2024. Dividend yield may amount to 3.47%.
Source: disclosure.skrin.ru
30.07.2024
IMCB's Board of Directors has recommended payment of a dividend from prior years' earnings of ₽5 per common share. Last day to purchase securities to receive the dividend is September 13, 2024. Dividend yield could be as high as 3.41%.
Source: e-disclosure.ru
e-disclosure.ru
General information
| Company name | IMCB |
|---|---|
| Tags | #biotechnology, #innovations of the russia, #stem cells |
| Sector | Health Care / Pharmaceuticals, Biotechnology & Life Sciences / Biotechnology / Biotechnology |
| Business address | gorod Moskva |
| Mailing address | 119333, g. Moskva, ul. Gubkina, d. 3, korp. 1, etazh 1, pom. 1, komn. 24 |
| CEO | Prihodko Aleksandr Viktorovich |
| Phone | +7(495) 646-80-76 |
| Website | invest.gemabank.ru |
| Information disclosure | e-disclosure.ru |
English (US) 